SCHOTT Pharma AG & Co. KGaA (1SXP.F)
EUR 23.72
(0.08%)
EUR 23.72
(0.08%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 47.97 Million EUR | 4.26% |
| 2022 | 46.01 Million EUR | 289.67% |
| 2021 | -24.26 Million EUR | -75.94% |
| 2020 | -13.78 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 71.56 Million EUR | 37.71% |
| 2024 Q2 | 51.97 Million EUR | 343.55% |
| 2024 Q1 | -21.33 Million EUR | -144.48% |
| 2023 Q4 | 47.97 Million EUR | 329.54% |
| 2023 FY | 47.97 Million EUR | 4.26% |
| 2023 Q3 | -20.9 Million EUR | 0.0% |
| 2023 Q2 | - EUR | 0.0% |
| 2023 Q1 | - EUR | -100.0% |
| 2022 FY | 46.01 Million EUR | 289.67% |
| 2022 Q4 | 46.01 Million EUR | 0.0% |
| 2021 FY | -24.26 Million EUR | -75.94% |
| 2020 FY | -13.78 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Carl Zeiss Meditec AG | 145.09 Million EUR | 66.936% |
| Fielmann Aktiengesellschaft | 593.44 Million EUR | 91.916% |
| Gerresheimer AG | 918.96 Million EUR | 94.78% |
| Sartorius Aktiengesellschaft | 4.93 Billion EUR | 99.027% |
| Sartorius Aktiengesellschaft | 4.93 Billion EUR | 99.027% |